Revista Portuguesa de Cardiologia · 2015 · 18 citations · 24 references
MedicineCardiologyInternal MedicineClinical CardiologyDiabetologyInterventional CardiologyChronic Total Occlusion InterventionCoronary AngioplastyCoronary Artery DiseaseIschemic Heart DiseasePercutaneous Coronary InterventionStent PlacementAngiographic SuccessChronic Total Occlusion AngioplastyChronic Total Occlusion Percutaneous Coronary InterventionClinical Outcomes After Percutaneous Coronary InterventionIn-stent ThrombosisPercutaneous Coronary Intervention CareRestenosis After StentingStent Patency Assessment
Diabetes mellitus and chronic total occlusions are associated with unfavorable outcome after percutaneous coronary intervention. We sought to assess the clinical and angiographic outcomes of diabetic and non-diabetic patients who underwent successful percutaneous revascularization of chronic total occlusions with drug-eluting stents. Baseline clinical and angiographic characteristics, procedural details, nine-month angiographic follow-up and clinical events at 12 months were compared between 75 diabetic and 132 non-diabetic patients included in a clinical trial that randomized successful recanalization of chronic total occlusions to receive sirolimus- or everolimus-eluting stents. In both diabetic and non-diabetic groups there was a favorable non-significantly different angiographic result at nine months, with low in-stent late loss (0.14±0.60 mm vs. 0.25±0.68 mm, p=0.305) and rates of binary restenosis (4.0% vs. 10.6%, p=0.180) and reocclusion (0.0% vs. 2.3%, p=0.334). During follow-up similar survival from death (97.3±1.9% vs. 99.2±0.8%, log-rank p=0.273), acute myocardial infarction (100.0±0.0% vs. 97.7±1.3%, log-rank p=0.192), target vessel revascularization (88.7±3.8% vs. 88.2±2.9%, log-rank p=0.899) and stent thrombosis (100.0±0.0% vs. 97.7±1.3%, log-rank p=0.192) was observed. Furthermore, the presence of more diffuse peripheral and coronary artery disease and higher frequency of calcified lesions in diabetic patients did not lead to significant differences in the approach (20.0% vs. 25.0% radial approach, p=0.413), strategy (6.7% vs. 3.8% retrograde strategy, p=0.353), total stent length (48.1±24.6 mm vs. 49.2±23.9 mm, p=0758) or contrast volume (261.3±116.4 ml vs. 297.4±135.9 ml, p=0.109) required for revascularization. In the drug-eluting stent era, diabetic and non-diabetic patients have comparable favorable clinical and angiographic outcomes after successful percutaneous revascularization of chronic total occlusions. A diabetes mellitus e as oclusões crónicas totais estão associadas a resultados desfavoráveis após intervenções coronárias percutâneas. Procurámos avaliar os resultados clínicos e angiográficos dos doentes diabéticos e não diabéticos que se submeteram a revascularização percutânea bem sucedida da oclusão crónica total com stents revestidos. Características clínicas e angiográficas de base, detalhes técnicos, seguimento angiográfico a 9 meses e eventos clínicos a 12 meses foram comparados entre 75 doentes diabéticos e 132 não diabéticos incluídos num estudo clínico que aleatorizou a recanalização bem sucedida da oclusão crónica total para receber o stent revestido com sirolimus ou com everolimus. Em ambos os grupos diabéticos e não diabéticos houve um resultado angiográfico deiferente favorável e não significativo aos 9 meses com baixa taxa de in-stent loss (0,14±0,60 mm versus 0,25±0,68 mm, p=0,305) e taxas de reestenose binária (4,0% versus 10,6%, p=0,180) e reoclusão (0,0% versus 2,3%, p=0,334). Durante o seguimento foi observada sobrevivência semelhante de morte (97,3±1,9% versus 99,2±0,8%, log-rank p=0,273), enfarte agudo do miocárdio (100,0±0,0% versus 97,7±1,3%, log-rank p=0,192), revascularização do vaso alvo (88,7±3,8% versus 88,2±2,9%, log-rank p=0,899), e trombólise de stent (100,0±0.0% versus 97,7±1,3%, log-rank p=0,192). Além disso, a presença de doença periférica mais difusa, de doença das artérias coronárias e frequência mais elevada de lesões calcificadas nos doentes diabéticos não implicou diferenças significativas na abordagem (abordagem radial 20,0 versus 25,0%, p=0,413), estratégia (estratégia retrógrada 6,7% versus 3,8%, p=0,353), comprimento total do stent (48,1±24,6 mm versus 49,2±23,9 mm, p=0,758) e volume de contraste (261,3±116,4 ml versus 297,4±135,9 ml, p=0,109), necessário para a revascularização. Na era dos stents revestidos, os doentes diabéticos e não diabéticos podem apresentar resultados clínicos e angiográficos comparáveis e favoráveis, após revascularização precutânea da oclusão crónica total.
24
Clinical End Points in Coronary Stent Trials
Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations
Strategies for Multivessel Revascularization in Patients with Diabetes
Michael E. Farkouh, Michaël Domanski, Lynn A. Sleeper et al. · New England Journal of Medicine · 2012 · 1.9K citations · Full text
Medicine, Cardiology, Surgery +15
Current Perspectives on Coronary Chronic Total Occlusions
Paul Fefer, Merril L. Knudtson, Asim N. Cheema et al. · Journal of the American College of Cardiology · 2012 · 801 citations
Medicine, Cardiology, Surgery +14
Effect of Diabetes Mellitus on Formation of Coronary Collateral Vessels
Adnan Abacı, Abdurrahman Oğuzhan, Sinan Kahraman et al. · Circulation · 1999 · 631 citations · Full text
Effect of Chronic Total Coronary Occlusion on Treatment Strategy
Ryan D. Christofferson, Kenneth G. Lehmann, Gary V. Martin et al. · The American Journal of Cardiology · 2005 · 438 citations
Medicine, Cardiology, Surgery +14